CAMP4 Therapeutics Corporation
USD4.50
+0.06 (+1.35%)
CEO
Joshua Mandel-Brehm
IPO Date
2024-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.50
Prev. Close
$4.44
Day Low
$4.44
Day High
$4.58
52W Low
$1.32
52W High
$7.75
Market Cap
$0.10B
Volume
0.08M
| -2.0 |
| 31 Dec 2023 | FY | 100.0% | -14083.1% | 39.8% | -89.7% | -0.09 | 5.13 | -2.6 |
| 28 Feb 2023 | FY | 0.0% | 0.0% | 57.0% | -43.1% | -0.16 | 10.62 | -8.8 |
| 28 Feb 2022 | FY | 41.2% | -10.5% | -38.8% | -7.7% | 2.61 | 2.04 | -12.1 |
| 28 Feb 2021 | FY | 39.7% | -6.9% | -21.3% | -4.8% | 2.12 | 2.00 | -17.3 |
| 29 Feb 2020 | FY | 39.1% | -21.5% | -57.1% | -15.9% | 1.70 | 1.96 | -4.6 |
| 28 Feb 2019 | FY | 40.6% | 5.1% | 8.9% | 3.0% | 1.34 | 4.83 | 20.2 |
| 28 Feb 2018 | FY | 41.2% | 4.5% | 8.4% | 3.5% | 0.78 | 2.89 | 22.7 |
| 28 Feb 2017 | FY | 40.8% | -2.0% | -4.4% | -1.8% | 0.90 | 2.70 | -53.8 |
| -2.0 |
| 30 Sept 2025 | Q3 | 47.7% | -1899.2% | -25.7% | -17.5% | 0.16 | 9.83 | -1.0 |
| 30 Jun 2025 | Q2 | 100.0% | -840.8% | -31.5% | -24.5% | 0.18 | 5.60 | -0.6 |
| 31 Mar 2025 | Q1 | 100.0% | -1449.1% | -24.1% | -19.8% | 0.15 | 8.02 | -1.6 |
| 31 Dec 2024 | Q4 | 100.0% | -2036.7% | -21.0% | -17.0% | 0.14 | 6.92 | -1.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 8.5% | -63.1% | -0.06 | 0.47 | -3.9 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 8.5% | -42.0% | -0.07 | 1.90 | -3.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -82.8% | -41.6% | 0.70 | 1.90 | -2.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 10.5% | -23.6% | -1.96 | 5.13 | -7.7 |